Variations in Single‐Point Insulin Sensitivity Estimator Index and the Risk of Cardiovascular Disease in Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0 to 3: A National Longitudinal Cohort Study
Sep 2026· Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease· Vol 15· 0 citations· 34 references
Medicine
TL;DR
Among individuals in cardiovascular-kidney-metabolic syndrome stages 0 to 3, both baseline and cumulative SPISE indices are independently and inversely associated with incident CVD risk, with this protective effect being particularly pronounced in men.
Abstract
Background Prior studies have focused exclusively on baseline single‐point insulin sensitivity estimator (SPISE) index levels, and the prognostic impact of longitudinal SPISE index trajectories on incident cardiovascular disease (CVD) remains unclear, particularly among individuals with cardiovascular–kidney–metabolic syndrome stages 0 to 3. This study investigated the prognostic value of dynamic SPISE index changes for CVD risk in this preclinical population. Methods This prospective cohort study used data from the CHARLS (China Health and Retirement Longitudinal Study). The SPISE index was calculated using body mass index, triglycerides, and high‐density lipoprotein cholesterol. We assessed longitudinal SPISE trajectories and cumulative SPISE index exposure by comparing measurements from wave 1 (baseline) and wave 3. Multivariable Cox proportional hazards models were used to evaluate associations of baseline, cumulative, and dynamic SPISE index profiles with incident CVD risk among participants at cardiovascular–kidney–metabolic stages 0 to 3. Results The longitudinal cohort comprised 7982 participants, and the cumulative exposure subcohort included 5288 participants. Compared with those with persistently high SPISE index, participants with SPISE index deterioration from high to low had significantly elevated CVD risk (hazard ratio [HR], 1.28 [95% CI, 1.06–1.53]), similar to those with a persistently low SPISE index (HR, 1.36 [95% CI, 1.18–1.56]). Participants in the highest tertiles of baseline and cumulative SPISE index had 22% and 29% lower CVD risk, respectively, with significant effect modification by sex. Conclusions Among individuals in cardiovascular–kidney–metabolic syndrome stages 0 to 3, both baseline and cumulative SPISE indices are independently and inversely associated with incident CVD risk, with this protective effect being particularly pronounced in men.
Baseline and cumulative TyG-WC demonstrated relatively better predictive performance and, especially baseline measure, may serve as a simple and low-cost auxiliary tool for cardiovascular risk stratification in resource-constrained primary care settings, though it should not replace conventional cardiovascular risk-ass...
Yan Xue, Qing-Xiu Tian, Rong Zhang et al.· Frontiers in Endocrinology· 0 citations
Cardiovascular–kidney–metabolic (CKM) syndrome integrates cardiovascular disease, chronic kidney disease, and metabolic risk factors, highlighting their interaction and shared progression. The cholesterol–HDL–glucose (CHG) index is a composite lipid–glucose index that may reflect metabolic dysfunction related to insuli...
Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...
Jiabaili Wang, Qian Liu, Meng-Hui Li et al.· Frontiers in Endocrinology· 0 citations
Cardiovascular-kidney-metabolic (CKM) syndrome integrates metabolic abnormalities, chronic kidney disease, and cardiovascular disease (CVD), with stages 0–3 representing a critical window for primary prevention. Whether the Chinese visceral adiposity index (CVAI) adds predictive value for CVD in this population r...
Long Feng, Geng Yang, He-Song Zeng et al.· Cardiovascular Diabetology· 0 citations
Higher two-visit cumulative TyG-nTLP burden was associated with incident CVD after accounting for competing death, and incremental discrimination was small, and shared laboratory components limit claims of biological independence or synergy.
Ao Lu, Qian Xu· Cardiovascular Diabetology· 0 citations
The modified cardiometabolic index (MCMI) has been proven to be closely associated with cardiovascular disease (CVD). However, most previous studies relied on single-point MCMI measurements, lacking comprehensive evaluations of long-term cumulative exposure and dynamic trajectories. This study aimed to investigat...